Stocks and InvestingStocks and Investing
Fri, April 16, 2021
Thu, April 15, 2021
Wed, April 14, 2021
Tue, April 13, 2021

Andrew Berens Maintained (ZNTL) at Buy with Increased Target to $64 on, Apr 13th, 2021


Published on 2024-10-27 16:13:37 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Increased Target from $60 to $64 on, Apr 13th, 2021.

Andrew has made no other calls on ZNTL in the last 4 months.



There are 3 other peers that have a rating on ZNTL. Out of the 3 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $65 on, Friday, March 26th, 2021
  • Robert Driscoll of "Wedbush" Initiated at Buy and Held Target at $65 on, Wednesday, January 20th, 2021
  • John Morrison of "Morgan Stanley" Maintained at Buy with Increased Target to $75 on, Wednesday, December 16th, 2020